Over $1M US in salary, a board seat, STI paid out at 75% and our CMO mucks up her first trial with the smallest population in our clinical investigation roadmap.
Bring on the AGM.
- Forums
- ASX - By Stock
- PAR
- Ann: Phase 2 Synovial Fluid Biomarker Study Update
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
1.19%
!
42.5¢

Ann: Phase 2 Synovial Fluid Biomarker Study Update, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
42.5¢ |
Change
0.005(1.19%) |
Mkt cap ! $169.9M |
Open | High | Low | Value | Volume |
42.0¢ | 43.5¢ | 41.5¢ | $214.0K | 503.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 19927 | 42.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
43.0¢ | 51217 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 19927 | 0.420 |
9 | 46047 | 0.415 |
9 | 109800 | 0.410 |
7 | 32461 | 0.405 |
10 | 171097 | 0.400 |
Price($) | Vol. | No. |
---|---|---|
0.430 | 51217 | 8 |
0.435 | 43087 | 7 |
0.440 | 89547 | 5 |
0.445 | 17161 | 4 |
0.450 | 91921 | 9 |
Last trade - 14.03pm 23/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |